Death from liver disease in a cohort of injecting opioid users in a Swedish city in relation to registration for opioid substitution therapy
暂无分享,去创建一个
[1] A. Widell,et al. Chronic hepatitis C in Swedish subjects receiving opiate substitution therapy—Factors associated with advanced fibrosis , 2014, Scandinavian journal of infectious diseases.
[2] H. Wand,et al. Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999–2011 , 2014, Journal of viral hepatitis.
[3] M. Hellard,et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. , 2014, International journal of epidemiology.
[4] A. Pharris,et al. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. , 2014, The International journal on drug policy.
[5] D. Randall,et al. The contributions of viral hepatitis and alcohol to liver-related deaths in opioid-dependent people. , 2013, Drug and alcohol dependence.
[6] C. Sabin,et al. Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997. , 2013, Gastroenterology.
[7] D. D. Des Jarlais,et al. Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] C. Bucello,et al. Mortality among people who inject drugs: a systematic review and meta-analysis. , 2013, Bulletin of the World Health Organization.
[9] K. Kielland,et al. All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: a controlled study. , 2013, Journal of hepatology.
[10] A. Muñoz,et al. Unhealthy Alcohol Use, HIV Infection and Risk of Liver Fibrosis in Drug Users with Hepatitis C , 2012, PloS one.
[11] C. Lewden,et al. All-cause and liver-related mortality in HIV positive subjects compared to the general population: differences by HCV co-infection. , 2012, Journal of hepatology.
[12] C. Mcgowan,et al. Barriers to hepatitis C treatment , 2012, Liver international : official journal of the International Association for the Study of the Liver.
[13] A. Widell,et al. The risk of cancer among persons with a history of injecting drug use in Sweden – a cohort study based on participants in a needle exchange program , 2012, Acta oncologica.
[14] D. Randall,et al. The increasing mortality burden of liver disease among opioid-dependent people: cohort study. , 2011, Addiction.
[15] A. Widell,et al. Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program , 2011, Journal of viral hepatitis.
[16] Louisa Degenhardt,et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews , 2011, The Lancet.
[17] L. Degenhardt,et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. , 2011, Addiction.
[18] I. Thiblin,et al. Were the changes to Sweden's maintenance treatment policy 2000-06 related to changes in opiate-related mortality and morbidity? , 2010, Addiction.
[19] M. Stenbacka,et al. Mortality and cause of death among 1705 illicit drug users: a 37 year follow up. , 2009, Drug and alcohol review.
[20] W. Hall,et al. Mortality among amphetamine users: a systematic review of cohort studies. , 2009, Drug and alcohol dependence.
[21] J. Raffa,et al. Low uptake of treatment for hepatitis C virus infection in a large community‐based study of inner city residents , 2009, Journal of viral hepatitis.
[22] L. Seeff. The history of the “natural history” of hepatitis C (1968–2009) , 2009, Liver international : official journal of the International Association for the Study of the Liver.
[23] A. Kamarulzaman. Global Epidemiology of Injecting Drug Use and HIV Among People Who Inject Drugs: A Systematic Review , 2008 .
[24] D. D. Des Jarlais,et al. Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place. , 2008, American journal of epidemiology.
[25] G. Dore,et al. Estimation of stage‐specific fibrosis progression rates in chronic hepatitis C virus infection: A meta‐analysis and meta‐regression , 2008, Hepatology.
[26] M. Berglund,et al. Factors associated with history of non-fatal overdose among opioid users in the Swedish criminal justice system. , 2008, Drug and alcohol dependence.
[27] Jason M. White,et al. Exposure to opioid maintenance treatment reduces long-term mortality. , 2008, Addiction.
[28] D. Vlahov,et al. Limited Uptake of Hepatitis C Treatment Among Injection Drug Users , 2008, Journal of Community Health.
[29] J. Whitfield,et al. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment. , 2007, Drug and alcohol review.
[30] I. Thiblin,et al. Methadone maintenance treatment: the balance between life-saving treatment and fatal poisonings. , 2007, Addiction.
[31] A. Helander,et al. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment. , 2007, Drug and alcohol review.
[32] C. Rück,et al. A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial. , 2007, The American journal of psychiatry.
[33] Johan Duflou,et al. Systemic disease among cases of fatal opioid toxicity. , 2006, Addiction.
[34] Kholoud Porter,et al. Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion , 2006, AIDS.
[35] S. Bird,et al. Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[36] C. Holman,et al. Mortality in a cohort of opiate and amphetamine users in Perth, Western Australia. , 2004, Addiction.
[37] J. Pawlotsky,et al. Impact of smoking on histological liver lesions in chronic hepatitis C , 2003, Gut.
[38] R. Mattick,et al. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. , 2003, The Cochrane database of systematic reviews.
[39] R P Mattick,et al. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. , 2009, The Cochrane database of systematic reviews.
[40] M. Sullivan,et al. Current perspectives on smoking cessation among substance abusers , 2002, Current psychiatry reports.
[41] M. Srisurapanont,et al. Treatment for amphetamine dependence and abuse. , 2014, The Cochrane database of systematic reviews.
[42] A. Mohsen,et al. The epidemiology of hepatitis C in a UK health regional population of 5.12 million , 2001, Gut.
[43] A. Widell,et al. Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program. , 2000, Scandinavian journal of infectious diseases.
[44] G. Ottomanelli. Methadone patients and alcohol abuse. , 1999, Journal of substance abuse treatment.
[45] J. Rajs,et al. Mortality and causes and manner of death among drug addicts in Stockholm during the period 1981–1992 , 1997, Acta psychiatrica Scandinavica.
[46] L. Öhlund,et al. Mortality in heroin addiction: impact of methadone treatment , 1990, Acta psychiatrica Scandinavica.